Colon adenocarcinoma cells inhibit anti-CD3-activated killer cell induction

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  1994-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF01525642PMID 8124689PMCID PMC11038949
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amelioration of experimental lung metastasis in mice by therapy with anti-CD3 monoclonal antibodies

  2004cited by this paper
• Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells

  2004cited by this paper
• Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody

  1993cited by this paper
• Superantigen‐induced cytokines suppress growth of human colon‐carcinoma cells

  1993cited by this paper
• Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cells.

  1992cited by this paper
• Production of a Suppressor of Lymphocyte Proliferation by Two Human Oral Carcinoma Cell Lines

  1992cited by this paper
• Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.

  1992cited by this paper
• Splenic Macrophages From Tumor‐Bearing Mice Co‐Expressing MAC‐1 and MAC‐2 Antigens Exert Immunoregulatory Functions Via Two Distinct Mechanisms

  1991cited by this paper
• Cytokine‐related syndrome following injection of anti‐CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation

  1990cited by this paper
• Selective immunosuppressive action of a factor produced by colon cancer cells.

  1990cited by this paper
• Comparison of cellular immunotherapies and anti-CD3 in the treatment of MCA-38-LD experimental hepatic metastases in C57BL/6 mice.

  1990cited by this paper
• Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.

  1990cited by this paper
• Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines.

  1989cited by this paper
• TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells.

  1989cited by this paper
• Growth factor production by human colon carcinoma cell lines.

  1989cited by this paper
• IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells.

  1989cited by this paper
• Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations.

  1989cited by this paper
• Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy.

  1989cited by this paper
• In vivo administration of anti-CD3 prevents malignant progressor tumor growth.

  1988cited by this paper
• The glioblastoma‐derived T‐cell suppressor factor/transforming growth factor beta2 inhibits the generation of lymphokineactivated killer (LAK) cells

  1988cited by this paper
• Transforming growth factor beta.

  1988cited by this paper
• Human transforming growth factor beta.alpha 2-macroglobulin complex is a latent form of transforming growth factor beta.

  1988cited by this paper
• Identification of a monoclonal antibody specific for a murine T3 polypeptide.

  1987cited by this paper
• Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.

  1987cited by this paper
• Evasion of host defences by tumours

  1987cited by this paper
• Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

  1986cited by this paper
• Activation of suppressor cells by low molecular weight factors secreted by spleen cells of tumor-bearing mice: modulatory role of prostaglandins.

  1986cited by this paper
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

  1982cited by this paper
• Prostaglandin: increased production by renal cell carcinoma.

  1977cited by this paper
• Prostaglandin: increased production by renal cell carcinoma.

  1977cited by this paper
• Suppression of lymphocyte activation by a factor produced by Mycoplasma arginini.

  1975cited by this paper

• Therapeutic potential of adenosine receptor modulators in cancer treatment

  2025cites this paper
• Current Understanding of the Role of Adenosine Receptors in Cancer

  2024cites this paper
• Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo.

  2021cites this paper
• Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer

  2018cites this paper
• CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice

  2017cites this paper
• Sodium Caseinate- stabilized Emulsion: A Carrier Matrix to Improve the Delivery of Epigallocatechin-gallate

  2016cites this paper
• Nanoencapsulation of Tea Catechins in Casein Micelles: Effects on Processing and Biological Functionalities

  2012cites this paper
• Adenosine receptors and cancer.

  2011cites this paper
• Adenosine receptors and cancer.

  2011cites this paper
• A3 Adenosine Receptor Regulation of Cells of the Immune System and Modulation of Inflammation

  2010cites this paper
• The A3 adenosine receptor: an enigmatic player in cell biology.

  2008cites this paper
• Adenosine and lymphocyte regulation

  2007cites this paper
• Adenosine acts through an A3 receptor to prevent the induction of murine anti‐CD3‐activated killer T cells

  2002cites this paper
• Adenosine suppresses alpha(4)beta(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells.

  2002cites this paper
• Statistical considerations in the methodology of quantifying immunocompetent cells in tumors.

  1999cites this paper
• Interleukin‐7 (IL‐7) in Colorectal Cancer: IL‐7 is Produced by Tissues from Colorectal Cancer and Promotes Preferential Expansion of Tumour Infiltrating Lymphocytes

  1997cites this paper
• Modulations of the effector function and cytokine production of human lymphocytes by secreted factors derived from colorectal‐carcinoma cells

  1997cites this paper
• Nonsteroidal antiinflammatory drugs and colorectal cancer.

  1996cites this paper
• Mucin-1-related T cell infiltration in colorectal carcinoma

  1996cites this paper
• Liver Metastases from Gastric Carcinoma: Report of a Patient Treated with Adoptive Immunotherapy (Tumor-Infiltrating Lymphocytes plus Interleukin-2 and Subsequently Local-Regional Lymphokine-Activated Killer Cells plus inTerleukin-2)

  1995cites this paper
• Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: Removal of tumour cells does not affect tumour-specificity

  1995cites this paper
• Cytotoxic Activity of CD4+ T Cells against Autologous Tumor Cells

  1995cites this paper
• Adenosine as a possible inhibitor of killer T‐cell activation in the microenvironment of solid tumours

  1994cites this paper